Heart failure & cardiomyopathiesResearch article

Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HF

Circ Heart FailPublished

  • analysis of patients implanted with a pulmonary artery pressure (PAP) sensor as part of the GUIDE-HF study

Authors' conclusion

These results may inform the selection of pharmacological therapy to manage elevated filling pressures during hemodynamic-guided therapy.

Study context

Population
Patients with heart failure implanted with a wireless pulmonary artery pressure sensor (CardioMEMS, Abbott) who newly initiated a core heart failure (HF) therapy at least 30 days post-implant and continued it for at least 30 days, without changes in loop diuretics or other core HF therapiespatients in the study, subsets with new initiation included in this analysis · new angiotensin receptor-neprilysin inhibitor initiation 50 · new sodium-glucose co-transporter-2 inhibitor initiation 97 · new mineralocorticoid receptor antagonist initiation 112 · new β-blocker initiation 33
Participants
2,358 patients
Comparison
PAP from 7 days pre-initiation vs the 7-day period following 30 days of newly initiated treatment with core HF therapies
  • angiotensin receptor-neprilysin inhibitorn = 50
  • sodium-glucose co-transporter-2 inhibitorn = 97
  • mineralocorticoid receptor antagonistn = 112
  • β-blockern = 33

Main finding

As reported in the abstract

Change in diastolic PAP · 7-day period following 30 days of treatment vs 7 days pre-initiation

angiotensin receptor-neprilysin inhibitor

−1.56

decrease · 95% CI −3.54–-0.40 · mm Hg

mineralocorticoid receptor antagonist

−1.15

decrease · 95% CI −1.82–-0.47 · mm Hg

Further findings

PAP after sodium-glucose co-transporter-2 inhibitor initiation

No detectable change in PAP

PAP after β-blocker initiation

Trend to higher PAP, differences not significant

Original publication

Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HF. Circ Heart Fail. Published 28 May 2026. doi:10.1161/circheartfailure.125.013877

Summarised from the published abstract; every number is checked against it